we RestorE IMMUNE RESILIENCE

Our Treatment Employs the Language of the Immune System
to Improve Patients' Health

Targeting the Underlying Cause of Disease

Autoimmune diseases cause lifelong suffering and disability for patients and place a significant burden on families and society

Our treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission

Our Approach

Our therapeutic approach derives from the understanding why most people do not develop autoimmune diseases despite being constantly exposed to a myriad of triggers. Using this knowledge, the company has developed a breakthrough therapy that is targeted, specific and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression

The Pipeline

Our platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline.
The company's lead programs are directed towards diseases of complex etiology in areas of signifiant unmet clinical need, with Inflamatory Bowel Disease (IBD) as our first clinical indication.

Alma Team

Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development and technology commercialization. It is supported by world-leading Scientific Advisors

Recent News

ECCO 2022

February 2022 – Alma attended ECCO 2022, the 17th congress of European Crohn’s and

To All News